Sekisui XenoTech have announced the addition of Rodent Hepatocytes to their patented CryostaX® product line.
The CryostaX® in vitro drug discovery and preclinical drug development test system is continuously expanding with these new pooled Sprague-Dawley rat hepatocytes released in July, and pooled CD-1 mouse hepatocytes soon to be launched.
CryostaX® hepatocytes are liver cells that are prepared using a patented process that produces unique cryopreserved cell pellets. This single-freeze preparation process provides greater convenience to researchers, versatile pooling options, and minimizes freeze-thaw injury to the cells, which promotes high viability, cell yield and enzymatic activity for longer-term, consistent test results. What else makes Cryostax a popular choice for researchers?